Literature DB >> 1760713

Effects of different lipid emulsions on lymphocyte function during total parenteral nutrition.

P C Sedman1, S S Somers, C W Ramsden, T G Brennan, P J Guillou.   

Abstract

A prospective randomized study of the immunological effects of three total parenteral nutrition (TPN) regimens in patients undergoing preoperative parenteral nutrition was conducted. In one regimen the calories were derived solely from glucose. The others were identical except that 50 per cent of the calories were provided as lipid emulsion, in one as long-chain triglycerides (LCT) only while the other contained half the fat as medium-chain triglycerides (MCT) and half as LCT (MCT/LCT). Natural killer (NK) activity and lymphokine-activated killer (LAK) activity were significantly higher after TPN with the MCT/LCT solution. A significant fall in LAK activity occurred after TPN with the LCT solution. The interleukin 2 content in supernatants from activated T lymphocytes was significantly higher after TPN with the LCT-containing solution. Solutions containing LCT and those containing MCT perturb cytokine interactions, but this is less with MCT-containing solutions, which may augment certain responses. These observations may have implications for the design of TPN regimens.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1760713     DOI: 10.1002/bjs.1800781142

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  16 in total

1.  Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition.

Authors:  Y Okada; N J Klein; H K van Saene; G Webb; H Holzel; A Pierro
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 2.  Death by parenteral nutrition.

Authors:  Paul E Marik; Michael Pinsky
Journal:  Intensive Care Med       Date:  2003-06       Impact factor: 17.440

3.  Expression of different lipoprotein receptors in natural killer cells and their effect on natural killer proliferative and cytotoxic activity.

Authors:  J B De Sanctis; I Blanca; N E Bianco
Journal:  Immunology       Date:  1995-11       Impact factor: 7.397

4.  Parenteral administration of medium- but not long-chain lipid emulsions may increase the risk for infections by Candida albicans.

Authors:  Geert J Wanten; Mihai G Netea; Ton H Naber; Jo H Curfs; Liesbeth E Jacobs; Trees J Verver-Jansen; Bart-Jan Kullberg
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

5.  The modulatory effect of lipids and glucose on the neonatal immune response induced by Staphylococcus epidermidis.

Authors:  Berit Haase; Kirstin Faust; Mathias Heidemann; Tasja Scholz; Martin Demmert; Birte Tröger; Alexander Herz; Christoph Härtel
Journal:  Inflamm Res       Date:  2011-03       Impact factor: 4.575

6.  Propofol emulsion reduces proliferative responses of lymphocytes from intensive care patients.

Authors:  C O Pirttikangas; J Perttilä; M Salo
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

7.  Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial.

Authors:  Sigrun Friesecke; Christian Lotze; Jenny Köhler; Annegret Heinrich; Stephan B Felix; Peter Abel
Journal:  Intensive Care Med       Date:  2008-03-21       Impact factor: 17.440

8.  Impairment of pulmonary macrophage function with total parenteral nutrition.

Authors:  J Shou; J Lappin; J M Daly
Journal:  Ann Surg       Date:  1994-03       Impact factor: 12.969

9.  The effects of long-term total parenteral nutrition on gut mucosal immunity in children with short bowel syndrome: a systematic review.

Authors:  Beyhan Duran
Journal:  BMC Nurs       Date:  2005-02-01

Review 10.  Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions.

Authors:  Philip C Calder; Gordon L Jensen; Berthold V Koletzko; Pierre Singer; Geert J A Wanten
Journal:  Intensive Care Med       Date:  2010-01-14       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.